SHANNON GLEASON: Open Payments
NPI 1366095820 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 62 payments from 20 companies in 2025. Trend: 2023 $761 · 2024 $1,144 · 2025 $1,040
Food & beverage: $1,040
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $228 |
| Amgen Inc. | 13 | $213 |
| Corcept Therapeutics | 11 | $160 |
| Insulet Corporation | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 2 | $53 |
| Medtronic, Inc. | 2 | $46 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| Echosens North America, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $22 |
Products named: Korlym, TEPEZZA, Rybelsus, Ozempic, Omnipod, VOQUEZNA, MINIMED 780G, Wegovy.
Industry payments across KY — which companies pay providers there.
